Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C5478 NCT-502Summary: inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) -
C5557 SR 1824Summary: non-agonist PPARγ ligand -
C5435 G3335Summary: PPARγ antagonist -
C5572 SR 2595Summary: inverse agonist of PPARγ -
C5491 trans-AUCBSummary: potent inhibitor of soluble epoxide hydrolase (sEH) -
A3756 RetaspimycinSummary: HSP90 inhibitor,antiproliferative and antineoplastic -
A3817 SildenafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, selective -
A3829 sodium 4-pentynoateSummary: chemical reporter for the profiling of acetylated proteins -
A3950 ZardaverineSummary: PDE III and IV inhibitor -
A4601 Empagliflozin (BI 10773)5 CitationSummary: SGLT-2 inhibitor for oral treatment of type 2 diabetes

